XML 25 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 14,713us-gaap_CashAndCashEquivalentsAtCarryingValue $ 49,511us-gaap_CashAndCashEquivalentsAtCarryingValue
Marketable securities available-for-sale 82,881us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent 73,141us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent
Accounts receivable 909us-gaap_AccountsReceivableNetCurrent 727us-gaap_AccountsReceivableNetCurrent
Prepaid expenses and other current assets 3,478us-gaap_PrepaidExpenseAndOtherAssetsCurrent 4,058us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Total current assets 101,981us-gaap_AssetsCurrent 127,437us-gaap_AssetsCurrent
Property and equipment, net 7,528us-gaap_PropertyPlantAndEquipmentNet 7,924us-gaap_PropertyPlantAndEquipmentNet
Goodwill 2,032us-gaap_Goodwill 2,277us-gaap_Goodwill
Restricted cash 608us-gaap_RestrictedCashAndCashEquivalentsNoncurrent 632us-gaap_RestrictedCashAndCashEquivalentsNoncurrent
Other assets 20us-gaap_OtherAssetsNoncurrent 20us-gaap_OtherAssetsNoncurrent
Total assets 112,169us-gaap_Assets 138,290us-gaap_Assets
Current liabilities:    
Accounts payable 3,272us-gaap_AccountsPayableCurrent 1,159us-gaap_AccountsPayableCurrent
Accrued research and development 7,346dvax_AccruedResearchAndDevelopmentExpensesCurrent 6,938dvax_AccruedResearchAndDevelopmentExpensesCurrent
Accrued liabilities 3,593us-gaap_AccruedLiabilitiesCurrent 6,317us-gaap_AccruedLiabilitiesCurrent
Deferred revenues 5,694us-gaap_DeferredRevenueCurrent 5,865us-gaap_DeferredRevenueCurrent
Long-term debt, current portion 594us-gaap_LongTermDebtCurrent  
Total current liabilities 20,499us-gaap_LiabilitiesCurrent 20,279us-gaap_LiabilitiesCurrent
Deferred revenues, net of current portion 6,599us-gaap_DeferredRevenueNoncurrent 6,900us-gaap_DeferredRevenueNoncurrent
Long-term debt 8,913us-gaap_LongTermDebt 9,559us-gaap_LongTermDebt
Other long-term liabilities 1,085us-gaap_OtherLiabilitiesNoncurrent 1,070us-gaap_OtherLiabilitiesNoncurrent
Total liabilities 37,096us-gaap_Liabilities 37,808us-gaap_Liabilities
Commitments and contingencies      
Stockholders’ equity:    
Common stock: $0.001 par value; 69,500 shares authorized at March 31, 2015 and December 31, 2014; 28,926 and 26,307 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively 29us-gaap_CommonStockValue 26us-gaap_CommonStockValue
Additional paid-in capital 697,149us-gaap_AdditionalPaidInCapitalCommonStock 695,058us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated other comprehensive loss (2,955)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax (1,669)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Accumulated deficit (619,150)us-gaap_RetainedEarningsAccumulatedDeficit (592,933)us-gaap_RetainedEarningsAccumulatedDeficit
Total stockholders’ equity 75,073us-gaap_StockholdersEquity 100,482us-gaap_StockholdersEquity
Total liabilities and stockholders’ equity 112,169us-gaap_LiabilitiesAndStockholdersEquity 138,290us-gaap_LiabilitiesAndStockholdersEquity
Series B Convertible Preferred Stock    
Stockholders’ equity:    
Preferred stock: $0.001 par value: Authorized: 5,000 shares; Issued and outstanding: Series B Convertible Preferred Stock — 17 shares at March 31, 2015 and 43 at December 31, 2014